CD8A and neoplasm: Flow cytometry analysis also showed the percentage of tumor‐infiltrating CD8+ T cells, an indicator of antitumor immunity activation, was 2.40‐fold higher in the “APHP‐CCCA+808+660” group compared to the PBS group (Figure 4H).